Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Adocia SA (ADOCY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
11.800.00 (0.00%)
At close: 10:06AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close11.80
Open11.80
BidN/A x N/A
AskN/A x N/A
Day's Range11.80 - 11.80
52 Week Range9.80 - 11.80
Volume200
Avg. Volume0
Market Cap92.279M
Beta (5Y Monthly)1.26
PE Ratio (TTM)N/A
EPS (TTM)-3.39
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ADOCY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ADOCIA
    Analyst Report: ageas SA/NVAgeas is a life and nonlife insurer covering Belgium, the rest of Europe, and Asia.
    Rating
    Fair Value
    Economic Moat
    last yearMorningstar
View more
  • Business Wire

    Adocia Announces Half Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets

    LYON, France, July 20, 2022--Regulatory News: Under the liquidity agreement entrusted by ADOCIA (Paris:ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on June 30th, 2022:

  • Business Wire

    Number of Shares and Voting Rights of ADOCIA as of June 30th, 2022

    LYON, France, July 11, 2022--Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF") charter ADOCIA SA (Paris:ADOC), a French société anonyme (corporation), 115, avenue Lacassagne, 69003 Lyon, (Euronext Paris: FR0011184241 – ADOC) a clinical stage biopharmaceutical company focused on treatment of diabetes, obesity and metabolic diseases with innovati

  • Business Wire

    Adocia Publishes its Letter to Shareholders

    LYON, France, June 23, 2022--Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC) (Paris:ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and other metabolic diseases, announced today the publication of the Letter to Shareholders for the 1st semester of 2022.

Advertisement
Advertisement